Overcoming prostate cancer drug resistance with a novel organosilicon small molecule

por Zhao, Rui, Ma, Xiaowei, Bai, Lijuan, Li, Xin, Mamouni, Kenza, Yang, Yang, Liu, HongYan, Danaher, Alira, Cook, Nicholas, Kucuk, Omer, Hodges, Robert S., Gera, Lajos, Wu, Daqing
Publicado 2021

Proteomics-Metabolomics Combined Approach Identifies Peroxidasin as a Protector against Metabolic and Oxidative Stress in Prostate Cancer

por Dougan, Jodi, Hawsawi, Ohuod, Burton, Liza J., Edwards, Gabrielle, Jones, Kia, Zou, Jin, Nagappan, Peri, Wang, Guangdi, Zhang, Qiang, Danaher, Alira, Bowen, Nathan, Hinton, Cimona, Odero-Marah, Valerie A.
Publicado 2019

Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models

por Bai, Lijuan, Li, Xin, Yang, Yang, Zhao, Rui, White, Elshaddai Z., Danaher, Alira, Bowen, Nathan J., Hinton, Cimona V., Cook, Nicholas, Li, Dehong, Wu, Alyssa Y., Qui, Min, Du, Yuhong, Fu, Haian, Kucuk, Omer, Wu, Daqing
Publicado 2023

Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer

por Li, Xin, Gera, Lajos, Zhang, Shumin, Chen, Yanhua, Lou, Lei, Wilson, Lauren Marie, Xie, Zhong-Ru, Sautto, Giuseppe, Liu, Degang, Danaher, Alira, Mamouni, Kenza, Yang, Yang, Du, Yuhong, Fu, Haian, Kucuk, Omer, Osunkoya, Adeboye O., Zhou, Jia, Wu, Daqing
Publicado 2021